Janssen VENTURA RWE

About the Study

The study aims to observe patients who are currently taking an SSRI/SNRI and who have had partial response to treatment and who are initiating or planning to initiate a new treatment for the current depressive episode would be observed over a 12 month period. New treatments may be pharmacological antidepressant treatment or non-pharmacological. Visits would be at baseline, then at 6 weeks, 6 months, 12 months, and at each event or treatment change.

Who is eligible?

• Aged 18-74 (inclusive)

• Diagnosis of Major Depressive Disorder

• Currently treated with an SSRI/SNRI at a therapeutic dose for >6 weeks

• Inadequate response to treatment with minimal/moderate symptomatic improvement (but not no response to treatment)

• Initiating or planning to initiate a new antidepressant treatment

If you would like to find out more about the Jansen Ventura RWE study, or have any questions, please contact your local study staff. These are:

Dr Katharine Taylor, Principal Investigator, CNTW, Email: Katharine.taylor@cntw.nhs.uk

Jamie Rea, Research Nurse, Email: Jamie.Rea@cntw.nhs.uk

Sarah Garner (Research Nurse), Email: Sarah.garner@cntw.nhs.uk

Recruitment to Jansen Venture RWE has now closed as we continue the study with the enrolled participants.